Susan Jeffrey

1.5k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Susan Jeffrey is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Susan Jeffrey has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Organic Chemistry. Recurrent topics in Susan Jeffrey's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (2 papers). Susan Jeffrey is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (2 papers). Susan Jeffrey collaborates with scholars based in United States, United Kingdom and New Zealand. Susan Jeffrey's co-authors include Lee Niswander, Cheryll Tickle, Gail R. Martin, Lee T. Bacheler, Beverly C. Cordova, Susan Erickson‐Viitanen, George L. Trainor, Soo S. Ko, Sharon Diamond and Ronald M. Klabe and has published in prestigious journals such as Nature, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Susan Jeffrey

7 papers receiving 1.2k citations

Hit Papers

A positive feedback loop coordinates growth and patternin... 1994 2026 2004 2015 1994 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A positive feedback loop coordinates growth and patterning in the vertebrate limb
    1994 594 citations Lee Niswander, Susan Jeffrey et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Jeffrey United States 7 689 352 305 258 170 8 1.2k
Radek Liboska Czechia 15 406 0.6× 136 0.4× 112 0.4× 19 0.1× 16 0.1× 43 563
T Ikeuchi Japan 8 507 0.7× 68 0.2× 213 0.7× 219 0.8× 37 0.2× 12 732
Eric Yu United States 11 376 0.5× 83 0.2× 33 0.1× 72 0.3× 59 0.3× 15 596
Christophe Caillat France 18 442 0.6× 32 0.1× 79 0.3× 126 0.5× 47 0.3× 20 601
Mary K. O’Reilly United States 9 402 0.6× 161 0.5× 49 0.2× 46 0.2× 30 0.2× 10 546
Joost H. van den Berg Netherlands 16 315 0.5× 20 0.1× 41 0.1× 28 0.1× 120 0.7× 31 856
Thierry Arnould France 14 820 1.2× 19 0.1× 51 0.2× 32 0.1× 264 1.6× 21 943
Nigar D. Babayeva United States 16 809 1.2× 13 0.0× 89 0.3× 191 0.7× 125 0.7× 27 982
Bart Degrève Belgium 14 308 0.4× 36 0.1× 90 0.3× 21 0.1× 169 1.0× 23 516
Alexander Karpeisky United States 16 897 1.3× 71 0.2× 48 0.2× 20 0.1× 46 0.3× 35 1.1k

Countries citing papers authored by Susan Jeffrey

Since Specialization
Citations

This map shows the geographic impact of Susan Jeffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Jeffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Jeffrey more than expected).

Fields of papers citing papers by Susan Jeffrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Jeffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Jeffrey. The network helps show where Susan Jeffrey may publish in the future.

Co-authorship network of co-authors of Susan Jeffrey

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Jeffrey. A scholar is included among the top collaborators of Susan Jeffrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Jeffrey. Susan Jeffrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kang, Il‐Ho, Chad Brabham, Jaeheon Lee, et al.. (2025). Dual mode of action herbicide rimisoxafen targets both phytoene desaturase and solanesyl diphosphate synthase. Pest Management Science. 81(10). 6330–6339.
2.
Cocuzza, Anthony J., Dennis R. Chidester, Beverly C. Cordova, et al.. (2001). Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain. Bioorganic & Medicinal Chemistry Letters. 11(9). 1177–1179. 67 indexed citations
3.
Bacheler, Lee T., Susan Jeffrey, George J. Hanna, et al.. (2001). Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy. Journal of Virology. 75(11). 4999–5008. 187 indexed citations
4.
Cocuzza, Anthony J., Dennis R. Chidester, Beverly C. Cordova, et al.. (2001). 4,1-Benzoxazepinone analogues of efavirenz (Sustiva™) as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(11). 1389–1392. 18 indexed citations
5.
Kaltenbach, Robert F., George L. Trainor, Daniel P. Getman, et al.. (2001). DPC 681 and DPC 684: Potent, Selective Inhibitors of Human Immunodeficiency Virus Protease Active against Clinically Relevant Mutant Variants. Antimicrobial Agents and Chemotherapy. 45(11). 3021–3028. 8 indexed citations
6.
Corbett, Jeffrey W., Soo S. Ko, James D. Rodgers, et al.. (2000). Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 43(10). 2019–2030. 272 indexed citations
7.
Corbett, Jeffrey W., Soo S. Ko, James D. Rodgers, et al.. (1999). Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 43(12). 2893–2897. 99 indexed citations
8.
Niswander, Lee, Susan Jeffrey, Gail R. Martin, & Cheryll Tickle. (1994). A positive feedback loop coordinates growth and patterning in the vertebrate limb. Nature. 371(6498). 609–612. 594 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radek Liboska Breakdown of academic impact, for papers by T Ikeuchi Breakdown of academic impact, for papers by Eric Yu Breakdown of academic impact, for papers by Christophe Caillat Breakdown of academic impact, for papers by Mary K. O’Reilly Breakdown of academic impact, for papers by Joost H. van den Berg Breakdown of academic impact, for papers by Thierry Arnould Breakdown of academic impact, for papers by Nigar D. Babayeva Breakdown of academic impact, for papers by Bart Degrève Breakdown of academic impact, for papers by Alexander Karpeisky
Rankless by CCL
2026